Skip to main
TFX
TFX logo

Teleflex (TFX) Stock Forecast & Price Target

Teleflex (TFX) Analyst Ratings

Based on 24 analyst ratings
Buy
Strong Buy 17%
Buy 33%
Hold 46%
Sell 4%
Strong Sell 0%

Bulls say

Teleflex is expected to experience at least 6% sales growth from its combined interventional business, with a solid foundation based on nearly $1 billion in revenue. Potential drivers for continued growth include stronger revenue performance, improved operating margins, and strategic acquisitions that align with higher growth expectations. Additionally, Teleflex's diversified product segments and a geographic focus on the US, which contributes 60% of revenue, position the company favorably for double-digit earnings growth and margin improvements in the future.

Bears say

Teleflex reported disappointing 4Q24 results, which included a significant miss on consensus revenue and EPS guidance for 2025, leading to a 22% decline in share value. The company projected a cautious revenue growth rate of only 1.0-2.0% year-over-year, well below market expectations of 4.5%, primarily due to anticipated challenges in segments such as UroLift and pressures from pricing dynamics in the office setting. Additionally, the firm announced a significant acquisition of Biotronik's Vascular Intervention business for approximately $820 million, although this move could be perceived as risky or dilutive to EPS, further contributing to a negative outlook.

Teleflex (TFX) has been analyzed by 24 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 33% recommend Buy, 46% suggest Holding, 4% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teleflex (TFX) Forecast

Analysts have given Teleflex (TFX) a Buy based on their latest research and market trends.

According to 24 analysts, Teleflex (TFX) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $255.92, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $255.92, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teleflex (TFX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.